Necroptosis in spontaneously-mutated hematopoietic cells induces autoimmune bone marrow failure in mice
Junping Xin,
Peter Breslin,
Wei Wei,
Jing Li,
Rafael Gutierrez,
Joseph Cannova,
Allen Ni,
Grace Ng,
Rachel Schmidt,
Haiyan Chen,
Vamsi Parini,
Paul C. Kuo,
Ameet R. Kini,
Patrick Stiff,
Jiang Zhu,
Jiwang Zhang
Affiliations
Junping Xin
Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL, USA;Research and Development Service, Hines VA Hospital, Hines, IL, USA;Department of Molecular Pharmacology and Therapeutics, Loyola University Medical Center, Maywood, IL, USA
Peter Breslin
Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL, USA;Department of Biology, Loyola University Chicago, IL, USA;Department of Molecular/Cellular Physiology, Loyola University Medical Center, Maywood, IL, USA
Wei Wei
Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL, USA
Jing Li
Department of Biology, College of Life and Environment Science, Shanghai Normal University, P.R. of China
Rafael Gutierrez
Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL, USA
Joseph Cannova
Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL, USA
Allen Ni
Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL, USA
Grace Ng
Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL, USA
Rachel Schmidt
Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL, USA
Haiyan Chen
Department of Pathology, Loyola University Medical Center, Maywood, IL, USA
Vamsi Parini
Department of Pathology, Loyola University Medical Center, Maywood, IL, USA
Paul C. Kuo
Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL, USA
Ameet R. Kini
Department of Pathology, Loyola University Medical Center, Maywood, IL, USA
Patrick Stiff
Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL, USA
Jiang Zhu
State Key Laboratory for Medical Genomics and Shanghai Institute of Hematology and Collaborative Innovation Center of Hematology, Rui-Jin Hospital; Shanghai Jiao-Tong University School of Medicine, P.R. of China
Jiwang Zhang
Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL, USA;Department of Pathology, Loyola University Medical Center, Maywood, IL, USA
Acquired aplastic anemia is an autoimmune-mediated bone marrow failure syndrome. The mechanism by which such an autoimmune reaction is initiated is unknown. Whether and how the genetic lesions detected in patients cause autoimmune bone marrow failure have not yet been determined. We found that mice with spontaneous deletion of the TGFβ-activated kinase-1 gene in a small subset of hematopoietic cells developed bone marrow failure which resembled the clinical manifestations of acquired aplastic anemia patients. Bone marrow failure in such mice could be reversed by depletion of CD4+ T lymphocytes or blocked by knockout of interferon-γ, suggesting a Th1-cell-mediated autoimmune mechanism. The onset and progression of bone marrow failure in such mice were significantly accelerated by the inactivation of tumor necrosis factor-α signaling. Tumor necrosis factor-α restricts autoimmune bone marrow failure by inhibiting type-1 T-cell responses and maintaining the function of myeloid-derived suppressor cells. Furthermore, we determined that necroptosis among a small subset of mutant hematopoietic cells is the cause of autoimmune bone marrow failure because such bone marrow failure can be prevented by deletion of receptor interacting protein kinase-3. Our study suggests a novel mechanism to explain the pathogenesis of autoimmune bone marrow failure.